Cytek Biosciences Reports Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 5, 2024
FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2024.
Read more at globenewswire.com
